article thumbnail

A Look Back at the Affordable Care Act

Drug Topics

The Affordable Care Act was passed in 2010 to make health care and prescription medicine more accessible. Did it succeed?

652
652
article thumbnail

Thoughts From the Streets: The Rise of Xylazine in Illicit Drug Use

Drug Topics

Rates of xylazine use have skyrocketed in since 2010, leading to an increase in overdoses and death.

469
469
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Themes of The World Pharmacists Day 2010-2020

Pharma Mirror

World Pharmacist Day is celebrated on 25th September every year since 2010 on the day FIP (International Pharmaceutical Federation) started their journey. The post The Themes of The World Pharmacists Day 2010-2020 appeared first on Pharma Mirror Magazine.

97
article thumbnail

Leverage Small Business Saturday to Drive Sales, Build Partnerships

Drug Topics

Small Business Saturday was created by American Express in 2010 and represents an important sales opportunity for independent community pharmacies across the United States.

article thumbnail

Minority Communities, Independent Storefronts Hit Hardest by Pharmacy Closures

Drug Topics

Researchers observed data from 2010 to 2021 to better understand recent trends in US pharmacy closures and the specific pharmacy types that have been impacted.

247
247
article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

article thumbnail

GLP-1, SGLT2 Prescriptions for Patients With T1D Increased Over Past Decade

Drug Topics

between 2010 and 2023. A recent study found the percentage of type 1 diabetes patients who were prescribed either GLP-1s or SGLT2 inhibitors increased from 0.7%

190
190